Investors Research Corp’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75
Closed -$4.44K 923
2025
Q4
$4.44K Hold
75
﹤0.01% 704
2025
Q3
$4.14K Hold
75
﹤0.01% 744
2025
Q2
$3.23K Hold
75
﹤0.01% 804
2025
Q1
$2.97K Hold
75
﹤0.01% 829
2024
Q4
$3.06K Hold
75
﹤0.01% 821
2024
Q3
$2.92K Hold
75
﹤0.01% 859
2024
Q2
$3.28K Hold
75
﹤0.01% 894
2024
Q1
$3.58K Hold
75
﹤0.01% 855
2023
Q4
$3.54K Hold
75
﹤0.01% 882
2023
Q3
$3.57K Hold
75
﹤0.01% 882
2023
Q2
$4.36K Hold
75
﹤0.01% 872
2023
Q1
$5.36K Hold
75
﹤0.01% 867
2022
Q4
$5.28K Hold
75
﹤0.01% 870
2022
Q3
$5K Hold
75
﹤0.01% 862
2022
Q2
$5K Hold
75
﹤0.01% 841
2022
Q1
$5K Hold
75
﹤0.01% 844
2021
Q4
$5K Hold
75
﹤0.01% 846
2021
Q3
$5K Hold
75
﹤0.01% 862
2021
Q2
$6K Hold
75
﹤0.01% 841
2021
Q1
$6K Hold
75
﹤0.01% 836
2020
Q4
$6K Hold
75
﹤0.01% 916
2020
Q3
$4K Hold
75
﹤0.01% 949
2020
Q2
$4K Hold
75
﹤0.01% 946
2020
Q1
$3K Hold
75
﹤0.01% 984
2019
Q4
$7K Hold
75
﹤0.01% 899
2019
Q3
$6K Hold
75
﹤0.01% 919
2019
Q2
$8K Hold
75
﹤0.01% 836
2019
Q1
$8K Buy
+75
New +$7.53K ﹤0.01% 819

Other funds holding NGVT

Investors Research Corp's NGVT Position: Q1 2026 in Review

Investors Research Corp sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 75 shares — an estimated $4.44K sold.

Investors Research Corp first reported a position in NGVT in Q1 2019 and held it in 28 quarters. The position peaked at $8K in Q2 2019. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Investors Research Corp reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Investors Research Corp sold 75 Ingevity shares in Q1 2026, an estimated $4.44K.
  • Investors Research Corp first reported a position in Ingevity in Q1 2019 and held it in 28 quarters.
  • Investors Research Corp's Ingevity position peaked at $8K in Q2 2019.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Investors Research Corp's 13F filing for Q1 2026, filed 3 Apr 2026.